Skip to content
10-Q

Quarterly Report

MOSAIC IMMUNOENGINEERING, INC. CPMV

0001683168-24-008258

← back to feed
Filed
Nov 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 7.24M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $5.74K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $156.18K
Current Liabilities Q3 2024 · Sep 30, 2024 $5.3M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.73M
Total Liabilities Q3 2024 · Sep 30, 2024 $6.68M
Total Liabilities Q3 2024 · Dec 31, 2023 $6.05M
Current Assets Q3 2024 · Sep 30, 2024 $39.95K
Current Assets Q3 2024 · Dec 31, 2023 $179.53K
Total Assets Q3 2024 · Sep 30, 2024 $39.95K
Total Assets Q3 2024 · Dec 31, 2023 $179.53K
Shares Diluted Q3 2024 · Sep 30, 2023 7.24M sh
Shares Diluted Q3 2024 · Sep 30, 2023 7.24M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$400.75K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$5.58M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$5.25M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$4.88M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.05
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.10
Eps Basic Q3 2024 · Sep 30, 2023 −$0.05
Eps Basic Q3 2024 · Sep 30, 2023 −$0.10
Rd Expense Q3 2024 · Sep 30, 2023 $84.93K
Rd Expense Q3 2024 · Sep 30, 2023 $385.46K
Net Income Q3 2024 · Sep 30, 2023 −$333.25K
Net Income Q3 2024 · Sep 30, 2023 −$712.68K
Operating Income Q3 2024 · Sep 30, 2023 −$311.87K
Operating Income Q3 2024 · Sep 30, 2023 −$1.12M